Drug slows progression of lung, breast cancer

ORLANDO, (Reuters) - Patients with advanced lung cancer or advanced breast cancer who took Genentech Inc.'s cancer drug Avastin in combination with chemotherapy took longer to relapse than patients who took chemotherapy alone, researchers said on Friday.

Continue to Drug slows progression of lung, breast cancer on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz